Skip to main content
64°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Avenacy
Avenacy Announces Launch of Leuprolide Acetate Injection in the U.S. Market
June 02, 2025
From
Avenacy
Via
Business Wire
Avenacy Announces Launch of Doxycycline for Injection, USP in the U.S. Market
May 27, 2025
From
Avenacy
Via
Business Wire
Avenacy Announces Launch of Propofol Injectable Emulsion, USP in the U.S. Market
April 07, 2025
From
Avenacy
Via
Business Wire
Avenacy Announces Launch of Five Injectable Antibiotic Products in the U.S. Market
March 17, 2025
From
Avenacy
Via
Business Wire
Avenacy to Attend 2025 DCAT Week
March 10, 2025
From
Avenacy
Via
Business Wire
Avenacy Announces Launch of Zoledronic Acid Injection, USP in the U.S. Market
February 18, 2025
From
Avenacy
Via
Business Wire
Avenacy Provides Update on 2025 Strategic Priorities Ahead of 43rd Annual J.P. Morgan Healthcare Conference
January 06, 2025
From
Avenacy
Via
Business Wire
Avenacy to Attend J.P. Morgan 43rd Annual Healthcare Conference
December 16, 2024
From
Avenacy
Via
Business Wire
Avenacy to Attend 2024 ASHP Midyear Clinical Meeting and Exhibition
December 02, 2024
From
Avenacy
Via
Business Wire
Avenacy Announces Launch of Dexmedetomidine Injection, USP in the U.S. Market
November 18, 2024
From
Avenacy
Via
Business Wire
Avenacy to Share Company’s Year One Progress at CPHI Milan 2024
September 23, 2024
From
Avenacy
Via
Business Wire
Avenacy Announces Launch of Metoclopramide Injection, USP in the U.S. Market
September 16, 2024
From
Avenacy
Via
Business Wire
Avenacy Announces Dr. Patrick Soon-Shiong as Major Investor, Co-founder and Board Member
August 20, 2024
From
Avenacy
Via
Business Wire
Avenacy Announces Launch of Palonosetron Hydrochloride Injection, USP in the U.S. Market
July 22, 2024
From
Avenacy
Via
Business Wire
Avenacy Announces Launch of Prochlorperazine Edisylate Injection, USP in the U.S. Market
June 26, 2024
From
Avenacy
Via
Business Wire
Avenacy Announces Launch of Tranexamic Acid Injection, USP in the U.S. Market
June 24, 2024
From
Avenacy
Via
Business Wire
Avenacy Announces Launch of Isoproterenol Hydrochloride Injection, USP in the U.S. Market
May 20, 2024
From
Avenacy
Via
Business Wire
Avenacy Announces Launch of Magnesium Sulfate in Water for Injection in the U.S. Market
May 14, 2024
From
Avenacy
Via
Business Wire
Avenacy Announces Launch of Eptifibatide for Injection in the U.S. Market
April 29, 2024
From
Avenacy
Via
Business Wire
Avenacy Announces Launch of Desmopressin Acetate for Injection in the U.S. Market
April 15, 2024
From
Avenacy
Via
Business Wire
Avenacy Announces Launch of Furosemide for Injection in the U.S. Market
March 20, 2024
From
Avenacy
Via
Business Wire
Avenacy Announces New Product Launches and Participation in DCAT Week 2024
March 18, 2024
From
Avenacy
Via
Business Wire
Avenacy Announces Launch of Bivalirudin for Injection in the U.S. Market
January 29, 2024
From
Avenacy
Via
Business Wire
Avenacy Announces Launch of Melphalan Hydrochloride for Injection in the U.S. Market
January 16, 2024
From
Avenacy
Via
Business Wire
Avenacy to Attend 2023 ASHP Midyear Clinical Meeting and Exhibition
November 27, 2023
From
Avenacy
Via
Business Wire
Avenacy Launches to Deliver Critical Medications
October 23, 2023
From
Avenacy
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.